Agilon Health (AGL) Equity Income (2022 - 2026)

Agilon Health (AGL) has reported Equity Income for 5 consecutive years, with $11.7 million the latest figure, recorded in Q1 2026.

• Equity Income for Q1 2026 came in at $11.7 million, down 7.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 112.62% YoY), and the FY2025 annual result was -$1.8 million, down 112.24% from the prior year.
• Equity Income was $11.7 million for Q1 2026 at Agilon Health, up from -$33.1 million in the prior quarter.
• Over five years, Equity Income peaked at $14.7 million in Q3 2023 and troughed at -$33.1 million in Q4 2025.
• Average Equity Income over 5 years is $3.0 million, with a median of $5.7 million recorded in 2024.
• The widest YoY moves for Equity Income: up 541.57% in 2025, down 1126.87% in 2025.
• Over 5 years, Equity Income stood at $7.2 million in 2022, then tumbled by 210.64% to -$8.0 million in 2023, then surged by 66.4% to -$2.7 million in 2024, then slumped by 1126.87% to -$33.1 million in 2025, then jumped by 135.5% to $11.7 million in 2026.
• Per Business Quant data, the three most recent Equity Income figures were $11.7 million in Q1 2026, -$33.1 million in Q4 2025, and $13.1 million in Q3 2025.